Daniel Eiger - Dissemin

All papers authored by Daniel Eiger

This paper was not found in any repository, but could be made available legally by the author.

2023 Diogo Martins-Branco

, Marie Kassapian, Véronique Debien

, Rafael Caparica

, Daniel Eiger

, Urania Dafni

, Charitini Andriakopoulou, Sarra El-Abed

, Susan L. Ellard

, Miguel Izquierdo, Malou Vicente, Saranya Chumsri, Martine Piccart-Gebhart

, Alvaro Moreno-Aspitia

, Ann Søegaard Knop and 2 other authors

The impact of erythropoiesis-stimulating agents administration concomitantly with adjuvant anti-HER2 treatments on the outcomes of patients with early breast cancer: a sub-analysis of the ALTTO study

Upload

2022 Jens Huober

, Carlos H. Barrios

, Naoki Niikura

, Michał Jarząb

, Yuan-Ching Chang

, Shannon L. Huggins-Puhalla, José Pedrini, Lyudmila Zhukova, Vilma Graupner, Daniel Eiger

, Volkmar Henschel, Nino Gochitashvili, Chiara Lambertini, Eleonora Restuccia, Hong Zhang

Atezolizumab With Neoadjuvant Anti–Human Epidermal Growth Factor Receptor 2 Therapy and Chemotherapy in Human Epidermal Growth Factor Receptor 2–Positive Early Breast Cancer: Primary Results of the Randomized Phase III IMpassion050 Trial

Upload

This paper is made freely available by the publisher.

Chau Dang

, Michael S. Ewer, Suzette Delaloge, Jean-Marc Ferrero, Ramon Colomer, Luis de la Cruz-Merino, Theresa L. Werner, Katherine Dadswell, Mark Verrill, Daniel Eiger

, Sriparna Sarkar, Sanne Lysbet de Haas, Eleonora Restuccia, Sandra M. Swain

BERENICE Final Analysis: Cardiac Safety Study of Neoadjuvant Pertuzumab, Trastuzumab, and Chemotherapy Followed by Adjuvant Pertuzumab and Trastuzumab in HER2-Positive Early Breast Cancer

Download from doi.org

2021 Maria Alice Franzoi

, Rita Saúde-Conde

, Sofia Cristóvão Ferreira

, Daniel Eiger

, Ahmad Awada, Evandro de Azambuja

Clinical outcomes of platinum-based chemotherapy in patients with advanced breast cancer: An 11-year single institutional experience

Upload

Daniel Eiger

, Elisa Agostinetto

, Rita Saúde-Conde

, Evandro de Azambuja

The Exciting New Field of HER2-Low Breast Cancer Treatment

Download from doi.org

2020 Maria Alice Franzoi

, Daniel Eiger

, Lieveke Ameye, Noam Ponde

, Rafael Caparica

, Claudia De Angelis

, Mariana Brandão, Evandro de Azambuja, Christine Desmedt

, Serena Di Cosimo, Nuria Kotecki, Matteo Lambertini

, Ahmad Awada, Martine Piccart, Evandro de Azambuja

Clinical Implications of Body Mass Index in Metastatic Breast Cancer Patients Treated With Abemaciclib and Endocrine Therapy

Upload

Maria Alice Franzoi, Caroline Vandeputte, Daniel Eiger

, Rafael Caparica, Mariana Brandão, Claudia De Angelis, Alain Hendlisz, Ahmad Awada, Martine Piccart, Evandro de Azambuja

Computed tomography-based analyses of baseline body composition parameters and changes in breast cancer patients under treatment with CDK 4/6 inhibitors

Upload

Daniel Eiger

, Noam F. Pondé, Dominique Agbor-Tarh, Alvaro Moreno-Aspitia, Martine Piccart, Florentine S. Hilbers, Olena Werner, Saranya Chumsri, Amylou Dueck, Judith R. Kroep, Henry Gomez, István Láng, Richard J. Rodeheffer, Michael S. Ewer, Thomas Suter and 1 other authors

Long-term cardiac outcomes of patients with HER2-positive breast cancer treated in the adjuvant lapatinib and/or trastuzumab Treatment Optimization Trial

Upload

Distributing this paper is prohibited by the publisher

Daniel Eiger

, Marcio Wagner

, Noam F. Pondé

, Melanie S. Nogueira

, Laurence Buisseret

, Evandro de Azambuja

The impact of cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i) on the incidence of alopecia in patients with metastatic breast cancer (BC)

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Daniel Eiger

, Mariana Brandão, Evandro de Azambuja

Lessons learned at SABCS 2019 and to-dos from immunotherapy in breast cancer

Upload

Daniel Eiger

, Maria Alice Franzoi, Noam Pondé, Mariana Brandão, Claudia de Angelis, Melanie Schmitt Nogueira

, Quentin de Hemptinne, Evandro de Azambuja

Cardiotoxicity of trastuzumab given for 12 months compared to shorter treatment periods: a systematic review and meta-analysis of six clinical trials

Upload

2019 M. Brandão

, R. Caparica

, D. Eiger

, E. de Azambuja

Biomarkers of response and resistance to PI3K inhibitors in estrogen receptor-positive breast cancer patients and combination therapies involving PI3K inhibitors

Upload

Daniel Eiger

, Noam Falbel Pondé, Evandro de Azambuja

Pertuzumab in HER2-positive early breast cancer: current use and perspectives

Upload

2018 Daniel Eiger

, Daniel Arcuschin de Oliveira

, Renato Leão de Oliveira

, Murilo Costa Sousa

, Mireille Darc Cavalcante Brandão

, ,Renato Santos de Oliveira Filho

Complete lymphadenectomy following positive sentinel lymph node biopsy in cutaneous melanoma: a critical review

Download from doi.org

Bernard Lobato Prado, Diogo Bugano Diniz Gomes, Pedro Luiz Serrano Usón Júnior, Patricia Taranto, Monique Sedlmaier França, Daniel Eiger

, Rodrigo Coutinho Mariano, David Hui, Auro Del Giglio

Continuous palliative sedation for patients with advanced cancer at a tertiary care cancer center

Download from doi.org

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

All papers authored by Daniel Eiger